Patent Assignment
Reel/Frame 036193/0178
Merger
Recorded: 2015-07-28
Pages: 22
Assignor
TAKEDA GMBH
Executed: 2012-10-25
Assignee
NYCOMED ASSET MANAGEMENT GMBH
BYK-GULDEN-STRASSE2, KONSTANZ, 78467, GERMANY
Covered Properties
(111)
Process for the Production of 16,17-[{Cyclohexylmethylen)Bis(Oxy)]-11,21-Dihydroxy-Pregna-1,4-Dien-3,20-Dion or Its 21-Isobutyrat by Transketalisation
Medicinal Product Package for Eradication Therapy
Freeze-Dried Pantoprazole Preparation and Pantoprazole Injection
Freeze-Dried Pantoprazole Preparation and Pantoprazole Injection
Freeze-dried pantoprazole preparation and pantoprazole injection
Pharmaceutical Preparation in the Form of a Paste Comprising an Acid-Labile Active Ingredient
Pharmaceutical Preparation in the Form of a Supension Comprising an Acid-Labile Active Ingredient
6-Phenylbenzonaphthyridines
Pharmaceutical Preparation Comprising an Active Dispersed on a Matrix
Pharmaceutical Preparation Comprising an Active Dispersed on a Matrix
Combination of a Nsaid and a Pde-4 Inhibitor
Ciclesonide Containing Aqueous Pharmaceutical Composition
Patent:
8,383,611 →
Application:
10/110,632 →
Novel Benzonaphthyridines
Novel Benzonaphthyridines
Novel Use of Pulmonary Surfactant
Use of PDE4 Inhibitors for the Treatment of Diabetes Mellitus
2-Hydroxy-6-Phenylphenanthridines as Pde-4 Inhibitors
2-Hydroxy-6-Phenylphenanthridines as Pde-4 Inhibitors
3-Hydroxy-6-Phenylphenanthridines as PDE4 Inhibitors
3-Hydroxy-6-Phenylphenanthridines as Pde-4 Inhibitors
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Salt of (S)-Pantoprazole and Its Hydrates
Pyrrolidinedione Substituted Piperidine-Phthalazones as PDE4 Inhibitors
Dosage form containing pantoprazole as active ingredient
Combination Medicament
Combination Medicament
Novel Use for PDE5 Inhibitors
Novel Use for PDE5 Inhibitors
Ciclesonide-Containing Sterile Aqueous Suspension
Ciclesonide-Containing Sterile Aqueous Suspension
Composition Comprising a Pulmonary Surfactant and a PDE5 Inhibitor for the Treatment of Lung Diseases
Formoterol and Ciclesonide Combination
Novel Medicine Pack
Triazolophthalazines
Use of Ciclesonide for the Treatment of Respiratory Diseases
Compliance monitor and method
2-(Piperidin-4-Yl)-4,5-Dihydro-2H-Pyridazin-3-One Derivatives as PDE4 Inhibitors
2-(Piperidin-4-Yl)-4,5-Dihydro-2H-Pyridazin-3-One Derivatives as PDE4 Inhibitors
Novel Guanidinyl-Substituted Hydroxy-6-Phenylphenanthridines
Novel Guanidinyl-Substituted Hydroxy-6-Phenylphenanthridines as Effective Phosphodiesterase (Pde) 4 Inhibitors
Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as PDE4 Inhibitors
Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as PDE4 Inhibitors
Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as PDE4 Inhibitors
Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as PDE4 Inhibitors
Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as PDE4 Inhibitors
Composition Comprising a Pulmonary Surfactant and a Tnf-Derived Peptide
Triazolophthalazines
Triazolophthalazines
Taste Masked Dosage Form Containing Roflumilast
Novel 3-Oxa-10-Aza-Phenanthrenes
Novel 3-Thia-10-Aza-Phenanthrene Derivatives
Novel 3-Thia-10-Aza-Phenanthrene Derivatives
Arrangement Comprising a Catheter and Connector Piece, and Valve for Passage of a Catheter
Roflumilast for the Treatment of Diabetes Mellitus Type 2
Roflumilast for the Treatment of Diabetes Mellitus
Roflumilast for the Treatment of Pulmonary Hypertension
Novel Salts of 6-Heterocycle Substituted Hexahydrophenanthridine Derivatives
Novel Salts of 6-Heterocycle Substituted Hexahydrophenanthridine Derivatives
Novel Salts of 6-Heterocycle Substituted Hexahydrophenanthridine Derivatives
Novel Salts of 6-Heterocycle Substituted Hexahydrophenanthridine Derivatives
Stable Pharmaceutical Products
Stable Pharmaceutical Products
Pyrazolone Derivatives as PDE4 Inhibitors
Pyrazolone Derivatives as PDE4 Inhibitors
SUBSTITUTED 7-CARBOXAMIDO-PYRROLO[3,2-d]PYRIMIDINES
Ciclesonide containing sterile aqueous suspension
Stabilized Pharmaceutical Product
Stabilized Pharmaceutical Product
Stabilized Pharmaceutical Product
Stabilized Pharmaceutical Product
Apparatus for the Aerosolization of Large Volumes of Dry Powder
Novel Pyrazolone-Derivatives and Their Use as Pde-4 Inhibitors
3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES
Methylpyrrolopyrimidinecarboxamides
Methylpyrrolopyridinecarboxamides
Oral-Admininistration Forms of a Medicament Containing Pantoprazol
Patent:
5,997,903 →
Application:
08/167,961 →
Synthetic Peptide Analogs of Lung Surface Protein Sp-C
Patent:
5,874,406 →
Application:
08/750,194 →
Prednisolone Derivatives
Patent:
5,733,901 →
Application:
08/530,173 →
Novel Silyl Compounds and Their Use
Patent:
5,728,826 →
Application:
08/704,574 →
Screening Kit and Process for Determining Action of Substances Inhibiting the P-Type Atpase Activity of Helicobacter Pylori
Patent:
5,981,184 →
Application:
08/849,480 →
Dihydrobenzofurans
Patent:
6,121,274 →
Application:
08/750,920 →
Process for R-Epimer Enrichment of 16,17-Acetal Derivatives of 21-Acyloxy Pregna-1,4-Dien-11.Beta. , 16.Alpha. , 17.Alpha.-Triol-3,20-Dione Derivatives
Patent:
6,787,533 →
Application:
09/147,675 →
Novel Benzofuran-4-Carboxamides
Patent:
6,211,203 →
Application:
09/147,640 →
Process for the Production of Powdered Pulmonary Surfactant Preparations
Patent:
6,315,983 →
Application:
09/117,142 →
Novel Phenanthridines Substituted in the 6 Position
Patent:
6,127,378 →
Application:
09/142,206 →
Compositions for the Treatment of Ards or Irds Containing 3- (Cyclopropylmethoxy) -N- (3,5-Dichloro-4-Pyridinyl) -4- (Difluoromethoxy) Benzamide and Lung Surfactant
Patent:
6,436,970 →
Application:
09/369,455 →
Novel Compositions
Novel Benzonaphthyridines
Patent:
6,008,215 →
Application:
09/284,458 →
Synergistic Combination of Pde Inhibitors and Adenylate Cyclase Agonists or Guanyl Cyclyse Agonists
Patent:
6,333,354 →
Application:
09/367,850 →
Synergistic Combination
Patent:
6,624,181 →
Application:
10/049,999 →
Synergistic Combination
Surfactant Protein C Esters
Surfactant Protein C Esters
Patent:
7,022,671 →
Application:
09/959,628 →
Medicinal Aerosol Formulation of Ciclesonide and Related Compounds
Patent:
6,264,923 →
Application:
09/440,797 →
Medicinal Aerosol Products
Patent:
6,120,752 →
Application:
09/076,958 →
Determination of the Hydrophobic Pulmonary Surfactant Protein Sp-C
Patent:
6,737,243 →
Application:
09/720,830 →
Process for Identification of Substances Modulating Urei Dependent Mechanisms of Helicobacter Pylori Metabolism
Patent:
5,942,409 →
Application:
09/126,326 →
Novel Salt Form of Pantoprazole
Patent:
6,410,569 →
Application:
09/762,303 →
Novel Salt Form of Pantoprazole
Synergistic Combination Comprising Roflumilast and a Pde-3 Inhibitor
Synergistic Combination Comprising Roflumilast and a Pde-3 Inhibitor
Patent:
6,498,173 →
Application:
09/959,599 →
Tetrahydropyridoethers
Tetrahydropyridoethers
Patent:
7,393,860 →
Application:
11/493,707 →
Phenylphennanthridines with Pde-Iv Inhibiting Activity
Patent:
6,476,025 →
Application:
09/889,144 →
3-Cyclopropylmethoxy-4-Difluoromethoxy-N-(3,5-Dichloropyrid-4-Yl)Benzamide in the Treatment of Multiple Sclerosis
Patent:
6,531,493 →
Application:
09/914,763 →
Combination of C1-Inh and Lung Surfactant for the Treatment of Respiratory Disorders
Patent:
7,053,176 →
Application:
10/088,294 →
New Pregna-1,4-DIENE3,20-Dione-16-17-Acetal-21 Esters, Process for Their Preparation, Composition, and Methods for the Treatment of Inflammatory Conditions
Patent:
5,482,934 →
Application:
08/278,112 →
Pyridopyrimidines
Patent:
5,925,642 →
Application:
09/068,936 →
Tetrahydropyridoethers
Patent:
6,436,953 →
Application:
09/582,212 →
Tetrahydropyridoethers
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 25, 2002
From: LINDER, RUDOLF; DIETRICH, RANGO
To: ALTANA PHARMA AG
Reel/Frame 013425/0992 →
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019781/0225 →
Change of Name
Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
Assignment of Assignor's Interest
Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Assignment of Assignor's Interest
Apr 17, 2017
From: TAKEDA GMBH
To: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Reel/Frame 042030/0371 →
Assignment of Assignor's Interest
Dec 10, 2018
From: ASTRAZENECA AB
To: COVIS PHARMA B.V.
Reel/Frame 047761/0435 →
Security Interest
Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest
Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest
Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement
Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Notice of Grant of Security Interest in Intellectual Property (First Lien)
Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →
Notice of Grant of Security Interest in Intellectual Property (Second Lien)
Feb 18, 2022
From: COVIS PHARMA GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059232/0514 →
Release of Security Interest
Jun 2, 2023
From: BARCLAYS BANK PLC
To: COVIS PHARMA GMBH
Reel/Frame 063841/0208 →
Release of Security Interest in Patents
Mar 17, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA GMBH
Reel/Frame 070537/0122 →